Group 1 - The core viewpoint of the articles highlights Huaxia Eye Hospital's stock performance, with a closing price of 20.91 yuan, an increase of 2.35%, and a rolling PE ratio of 41.58, marking a new low in 97 days, with a total market value of 17.564 billion yuan [1] - The average PE ratio for the medical services industry is 48.03, with a median of 60.62, placing Huaxia Eye Hospital at the 26th position within the industry [1] - On August 11, Huaxia Eye Hospital experienced a net inflow of main funds amounting to 8.5187 million yuan, with a total inflow of 7.3312 million yuan over the past five days [1] Group 2 - Huaxia Eye Hospital's main business focuses on specialized ophthalmic medical services, with key products including cataract projects, posterior segment projects, refractive projects, and comprehensive optometry projects [1] - The latest quarterly report for Q1 2025 shows that the company achieved an operating income of 1.093 billion yuan, a year-on-year increase of 11.74%, and a net profit of 150 million yuan, reflecting a year-on-year decrease of 4.00%, with a gross profit margin of 44.97% [1] - The PE ratio (TTM) for Huaxia Eye Hospital is 41.58, while the industry average is 48.03, and the industry median is 60.62 [2]
华厦眼科收盘上涨2.35%，滚动市盈率41.58倍，总市值175.64亿元